AXIN1 Gene Mutation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which AXIN1 Gene Mutation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 2

NCT06005974

A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation

This is a multi-center, open-label study to investigate the safety, efficacy and pharmacokinetics of REC-4881 (12 mg PO daily doses) for the treatment of partic…

United States18 participantsStarted 2024-01-15

Treatment: REC-4881